Literature DB >> 15075988

Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy.

Gwo-Tzer Ho1, Anne Parker, John F MacKenzie, A John Morris, Adrian J Stanley.   

Abstract

INTRODUCTION: Liver dysfunction is common in bone marrow transplant recipients. Common causes are graft-versus-host disease, drugs, veno-occlusive disease, sepsis and iron overload. We studied the prevalence and aetiology of abnormal liver function tests following bone marrow transplantation and the role of liver biopsy.
METHODS: All allogeneic and autologous bone marrow transplantations undertaken in our institution over a 2-year period were studied. Subsequent liver function tests, the use and timing of liver biopsy and the final cause of liver dysfunction were determined in each case.
RESULTS: We studied 121 patients (58 allogeneic, 63 autologous). Abnormal liver function tests were found in 52% of bone marrow transplant recipients (72% allogeneic and 33% autologous; P = 0.015). The most common causes of liver dysfunction were graft-versus-host disease, drugs and iron overload in the allogeneic group, and drugs and sepsis in the autologous group. Nineteen patients (16%; 18 allogeneic) underwent liver biopsy. The majority of liver biopsies were carried out in the late post-transplant period to exclude or confirm graft-versus-host disease, although only one case was confirmed. Sixteen of the 19 patients who underwent biopsy had significant hepatic iron overload, but no biopsy revealed evidence of fibrosis or cirrhosis.
CONCLUSION: Liver dysfunction following bone marrow transplantation is common and most diagnoses can be ascertained without resorting to liver biopsy. In our series, hepatic iron overload was the most common finding in those who underwent liver biopsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075988     DOI: 10.1097/00042737-200402000-00006

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

1.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

2.  Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

Authors:  Philippe Armand; Haesook T Kim; Corey S Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Robert J Soiffer; Joseph H Antin
Journal:  Blood       Date:  2007-01-18       Impact factor: 22.113

Review 3.  Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.

Authors:  H Joachim Deeg; Emily Spaulding; Howard M Shulman
Journal:  Leuk Lymphoma       Date:  2009-10

4.  A Case of Drug-Induced Hepatitis due to Lenalidomide.

Authors:  M-C Zanella; L Rubbia-Brandt; E Giostra; Y Chalandon; A Hadengue; L Spahr
Journal:  Case Rep Gastroenterol       Date:  2011-04-13

5.  Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.

Authors:  Judith Stift; Hideo A Baba; Elisabeth Huber; Birgit Federmann; Hans-Peter Fischer; Annette Schmitt-Graeff; Herrad Baurmann; Wolfgang Bethge; Peter Schirmacher; Fritz Wrba; Hildegard Greinix; Falko Fend; Rainer Schwerdtfeger; Howard M Shulman; Daniel Wolff; Thomas Longerich
Journal:  Virchows Arch       Date:  2014-01-03       Impact factor: 4.535

6.  Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients.

Authors:  Bora Kim; Ji Won Lee; Kyung Taek Hong; Kyung-Sang Yu; In-Jin Jang; Kyung Duk Park; Hee Young Shin; Hyo Seop Ahn; Joo-Youn Cho; Hyoung Jin Kang
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

7.  Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.

Authors:  M Sakai; S I Strasser; H M Shulman; S J McDonald; H G Schoch; G B McDonald
Journal:  Bone Marrow Transplant       Date:  2009-03-23       Impact factor: 5.483

8.  Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children.

Authors:  J W Lee; H J Kang; E K Kim; H Kim; H Y Shin; H S Ahn
Journal:  Bone Marrow Transplant       Date:  2009-04-27       Impact factor: 5.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.